Clinical Trial Update: Study to Nivolumab Following Preoperative Chemoradiotherapy [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial investigating nivolumab after preoperative chemoradiotherapy for rectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: Takayuki Yoshino | Conditions: Cancer of Rectum | Phase 1, Phase 2 | Status: UNKNOWN